Evoke Pharma Begins Trading on Nasdaq – San Diego Business Journal
|
Evoke Pharma Begins Trading on Nasdaq
San Diego Business Journal Evoke Pharma Inc. began trading on the Nasdaq Sept. 25 with an initial public offering of 2.1 million shares priced at $ 12 a share. The company's expected gross proceeds were $ 25.2 million. The company, which develops treatments for gastrointestinal … |
